BiotechTube
Home/Tagworks Pharmaceuticals/Ken Mills
KM

Ken Mills

CEO

Tagworks Pharmaceuticals

Therapeutic Areas

Oncology

Tagworks Pharmaceuticals Pipeline

DrugIndicationPhase
TGW101Advanced Solid Tumors (TAG72+)Phase 1
TGW211HER2+ TumorsPhase 0/1

Leadership Team at Tagworks Pharmaceuticals

MR
Marc Robillard, PhD
CSO & Co-founder
KO
Keith Orford, MD/PhD
CMO
RR
Raffaella Rossin, PhD
Head of Discovery & Co-founder
View full Tagworks Pharmaceuticals profile